Literature DB >> 8069084

What is the best protocol for ovarian superovulation?

B Hedon1, B Camier, F Arnal, C Humeau.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8069084     DOI: 10.1007/bf01212930

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  9 in total

1.  The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials.

Authors:  E G Hughes; D M Fedorkow; S Daya; M A Sagle; P Van de Koppel; J A Collins
Journal:  Fertil Steril       Date:  1992-11       Impact factor: 7.329

2.  Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression.

Authors:  M C Edelstein; R G Brzyski; G S Jones; S Simonetti; S J Muasher
Journal:  Fertil Steril       Date:  1990-01       Impact factor: 7.329

3.  Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention.

Authors:  R G Forman; R Frydman; D Egan; C Ross; D H Barlow
Journal:  Fertil Steril       Date:  1990-03       Impact factor: 7.329

4.  Recurrent abnormal follicular maturation and ovarian stimulation for in-vitro fertilization.

Authors:  B Hedon; J Bringer; S Neveu; F Arnal; F Montera; C Humeau
Journal:  Hum Reprod       Date:  1988-05       Impact factor: 6.918

5.  Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation.

Authors:  C M Howles; M C Macnamee; R G Edwards; R Goswamy; P C Steptoe
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321

6.  Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization.

Authors:  S Neveu; B Hedon; J Bringer; J M Chinchole; F Arnal; C Humeau; P Cristol; J L Viala
Journal:  Fertil Steril       Date:  1987-04       Impact factor: 7.329

7.  [Evaluation of FIVNAT 1992].

Authors:  A Roalier; A Bachelot; J de Mouzon; P Rufat; H Logerot
Journal:  Contracept Fertil Sex       Date:  1993-05

8.  Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase.

Authors:  J D Stanger; J L Yovich
Journal:  Br J Obstet Gynaecol       Date:  1985-04

9.  Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG.

Authors:  Z Ben-Rafael; D Bider; U Dan; M Zolti; D Levran; S Mashiach
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.